Jpmorgan Chase & CO Nevro Corp Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Nevro Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 231,102 shares of NVRO stock, worth $917,474. This represents 0.0% of its overall portfolio holdings.

Number of Shares
231,102
Previous 147,090 57.12%
Holding current value
$917,474
Previous $1.24 Million 4.12%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
BUY
$4.71 - $10.1 $395,696 - $848,521
84,012 Added 57.12%
231,102 $1.29 Million
Q3 2024

Nov 08, 2024
BUY
$4.71 - $10.1 $395,696 - $848,521
84,012 Added 57.12%
231,102 $1.29 Million
Q2 2024

Dec 26, 2024
SELL
$7.96 - $13.59 $668,735 - $1.14 Million
-84,012 Reduced 36.35%
147,090 $1.24 Million
Q2 2024

Aug 12, 2024
BUY
$7.96 - $13.59 $199,167 - $340,035
25,021 Added 20.5%
147,090 $1.24 Million
Q1 2024

Dec 26, 2024
SELL
$13.56 - $20.78 $1.48 Million - $2.27 Million
-109,033 Reduced 47.18%
122,069 $1.76 Million
Q1 2024

May 10, 2024
BUY
$13.56 - $20.78 $643,964 - $986,842
47,490 Added 63.68%
122,069 $1.76 Million
Q4 2023

Dec 26, 2024
SELL
$14.18 - $22.31 $2.22 Million - $3.49 Million
-156,523 Reduced 67.73%
74,579 $1.6 Million
Q4 2023

Feb 12, 2024
SELL
$14.18 - $22.31 $617,212 - $971,087
-43,527 Reduced 36.85%
74,579 $1.6 Million
Q3 2023

Nov 14, 2023
SELL
$18.22 - $25.85 $196,757 - $279,154
-10,799 Reduced 8.38%
118,106 $2.27 Million
Q2 2023

Aug 11, 2023
BUY
$22.62 - $39.32 $62,906 - $109,348
2,781 Added 2.2%
128,905 $3.28 Million
Q1 2023

May 18, 2023
BUY
$30.17 - $41.11 $1.33 Million - $1.81 Million
44,089 Added 53.74%
126,124 $4.56 Million
Q1 2023

May 11, 2023
SELL
$30.17 - $41.11 $42.3 Million - $57.7 Million
-1,403,436 Reduced 94.48%
82,035 $2.97 Million
Q4 2022

Feb 13, 2023
SELL
$36.43 - $49.4 $4.11 Million - $5.57 Million
-112,798 Reduced 7.06%
1,485,471 $58.8 Million
Q3 2022

Nov 14, 2022
BUY
$40.66 - $53.03 $8.99 Million - $11.7 Million
221,158 Added 16.06%
1,598,269 $74.5 Million
Q2 2022

Aug 11, 2022
BUY
$40.85 - $77.67 $446,286 - $848,544
10,925 Added 0.8%
1,377,111 $60.4 Million
Q1 2022

May 11, 2022
BUY
$59.95 - $92.06 $11.4 Million - $17.5 Million
189,887 Added 16.14%
1,366,186 $98.8 Million
Q4 2021

Feb 10, 2022
BUY
$81.07 - $121.29 $60,559 - $90,603
747 Added 0.06%
1,176,299 $95.4 Million
Q3 2021

Nov 12, 2021
BUY
$101.99 - $166.36 $120 Million - $196 Million
1,175,552 New
1,175,552 $137 Million

Others Institutions Holding NVRO

# of Institutions
151
Shares Held
39.3M
Call Options Held
67.9K
Put Options Held
1.59M
View Full List

About NEVRO CORP

NVRO Quotes by TradingView
  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $140M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email